SCHEMBL21026753

SCHEMBL21026753

NC(=O)/C=C/CN1CCN(C2CC2)CC1

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 4/20 0.36
ITGB3 P05106 1/20 0.35
ITGA2B P08514 1/20 0.35
ALOX15 P16050 2/20 0.34
KDM4E B2RXH2 5/20 0.33
ALDH1A1 P00352 4/20 0.33
PARP1 P09874 1/20 0.32
PARP2 Q9UGN5 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
CHRM1 P11229 3/20 0.32
TRPV6 Q9H1D0 2/20 0.32
HRH3 Q9Y5N1 3/20 0.31
KCNH2 Q12809 1/20 0.31
CHRM5 P08912 2/20 0.31
CHRM2 P08172 1/20 0.31
CHRM4 P08173 1/20 0.31
CHRM3 P20309 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21027688 0.83 SIGMAR1 (0.35) SIGMAR1ITGB3ITGA2BALOX15KDM4E
SCHEMBL17150483 0.83 KDM4E (0.36) SIGMAR1ALOX15KDM4EALDH1A1TDP1
SCHEMBL23336316 0.82 SIGMAR1 (0.37) SIGMAR1ITGB3ITGA2BALOX15KDM4E
SCHEMBL19040084 0.81 KDM4E (0.36) SIGMAR1ALOX15KDM4EALDH1A1TDP1
SCHEMBL19054969 0.80 SIGMAR1 (0.38) SIGMAR1ALOX15KDM4EALDH1A1TDP1
SCHEMBL16665113 0.80 SIGMAR1 (0.38) SIGMAR1ALOX15KDM4EALDH1A1CHRM1
SCHEMBL29659499 0.79 SMN1; SMN2 (0.35) HRH3
SCHEMBL16653865 0.77 L3MBTL1 (0.42) ALDH1A1MEN1KMT2A
SCHEMBL29265688 0.77 L3MBTL1 (0.42) ALDH1A1MEN1KMT2A
SCHEMBL16653961 0.77 PAOX (0.38) SIGMAR1ALOX15KDM4EALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3489232-A2 INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) Syros Pharmaceuticals, Inc. (US) 2019-05-29 EP disclosed